Cytosolic aggregation of mitochondrial proteins disrupts cellular homeostasis by stimulating the aggregation of other proteins

Abstract

Mitochondria are organelles with their own genomes, but they rely on the import of nuclear-encoded proteins that are translated by cytosolic ribosomes. Therefore, it is important to understand whether failures in the mitochondrial uptake of these nuclear-encoded proteins can cause proteotoxic stress and identify response mechanisms that may counteract it. Here, we report that upon impairments in mitochondrial protein import, high-risk precursor and immature forms of mitochondrial proteins form aberrant deposits in the cytosol. These deposits then cause further cytosolic accumulation and consequently aggregation of other mitochondrial proteins and disease-related proteins, including α-synuclein and amyloid β. This aggregation triggers a cytosolic protein homeostasis imbalance that is accompanied by specific molecular chaperone responses at both the transcriptomic and protein levels. Altogether, our results provide evidence that mitochondrial dysfunction, specifically protein import defects, contributes to impairments in protein homeostasis, thus revealing a possible molecular mechanism by which mitochondria are involved in neurodegenerative diseases.

Data availability

Sequencing data have been deposited in GEO under accession codes GSE147284

The following data sets were generated

Article and author information

Author details

  1. Urszula Nowicka

    Centre of New Technologies, University of Warsaw, Warsaw, Poland
    Competing interests
    No competing interests declared.
  2. Piotr Chroscicki

    Centre of New Technologies, University of Warsaw, Warsaw, Poland
    Competing interests
    No competing interests declared.
  3. Karen Stroobants

    Department of Chemistry, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
  4. Maria Sladowska

    Centre of New Technologies, University of Warsaw, Warsaw, Poland
    Competing interests
    No competing interests declared.
  5. Michal Turek

    Centre of New Technologies, University of Warsaw, Warsaw, Poland
    Competing interests
    No competing interests declared.
  6. Barbara Uszczynska-Ratajczak

    Centre of New Technologies, University of Warsaw, Warsaw, Poland
    Competing interests
    No competing interests declared.
  7. Rishika Kundra

    Department of Chemistry, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
  8. Tomasz Goral

    Centre of New Technologies, University of Warsaw, Warsaw, Poland
    Competing interests
    No competing interests declared.
  9. Michele Perni

    Chemistry, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7593-8376
  10. Christopher M Dobson

    Department of Chemistry, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
  11. Michele Vendruscolo

    Department of Chemistry, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3616-1610
  12. Agnieszka Chacinska

    Centre of New Technologies, University of Warsaw, Warsaw, Poland
    For correspondence
    a.chacinska@imol.institute
    Competing interests
    Agnieszka Chacinska, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2832-2568

Funding

Centre for Misfolding Diseases

  • Michele Vendruscolo

National Science Centre (2015/18/A/NZ1/00025)

  • Agnieszka Chacinska

Ministerial funds for science (Ideas Plus,000263)

  • Agnieszka Chacinska

Foundation of Polish Science and German Research Foundation (Copernicus Award)

  • Agnieszka Chacinska

Foundation for Polish Science co-financed by the European Union under the Eropean Regional Development Fund (Homing,POIR.04.04.00-00-3FE4/17)

  • Urszula Nowicka

European Union's Horizon 2020, Marie Sklodowska-Curie grant agreement No 665778 (POLONEZ,2016/23/P/NZ3/03730)

  • Barbara Uszczynska-Ratajczak

European Union's Horizon 2020, Marie Sklodowska-Curie grant agreement No 665778 (POLONEZ,2016/21JPJNZ3/03891)

  • Michal Turek

EMBO (Short-term fellowship,7124)

  • Maria Sladowska

William B. Harrison Foundation

  • Michele Vendruscolo

Foundation for Polish Science co-financed by the European Union under the Eropean Regional Development Fund (International Research Agendas programme, Regenerative Mechanisms for Health, MAB/2017/2)

  • Agnieszka Chacinska

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Nowicka et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,038
    views
  • 801
    downloads
  • 64
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Urszula Nowicka
  2. Piotr Chroscicki
  3. Karen Stroobants
  4. Maria Sladowska
  5. Michal Turek
  6. Barbara Uszczynska-Ratajczak
  7. Rishika Kundra
  8. Tomasz Goral
  9. Michele Perni
  10. Christopher M Dobson
  11. Michele Vendruscolo
  12. Agnieszka Chacinska
(2021)
Cytosolic aggregation of mitochondrial proteins disrupts cellular homeostasis by stimulating the aggregation of other proteins
eLife 10:e65484.
https://doi.org/10.7554/eLife.65484

Share this article

https://doi.org/10.7554/eLife.65484

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Katherine A Senn, Karli A Lipinski ... Aaron A Hoskins
    Research Article

    Pre-mRNA splicing is catalyzed in two steps: 5ʹ splice site (SS) cleavage and exon ligation. A number of proteins transiently associate with spliceosomes to specifically impact these steps (first and second step factors). We recently identified Fyv6 (FAM192A in humans) as a second step factor in Saccharomyces cerevisiae; however, we did not determine how widespread Fyv6’s impact is on the transcriptome. To answer this question, we have used RNA sequencing (RNA-seq) to analyze changes in splicing. These results show that loss of Fyv6 results in activation of non-consensus, branch point (BP) proximal 3ʹ SS transcriptome-wide. To identify the molecular basis of these observations, we determined a high-resolution cryo-electron microscopy (cryo-EM) structure of a yeast product complex spliceosome containing Fyv6 at 2.3 Å. The structure reveals that Fyv6 is the only second step factor that contacts the Prp22 ATPase and that Fyv6 binding is mutually exclusive with that of the first step factor Yju2. We then use this structure to dissect Fyv6 functional domains and interpret results of a genetic screen for fyv6Δ suppressor mutations. The combined transcriptomic, structural, and genetic studies allow us to propose a model in which Yju2/Fyv6 exchange facilitates exon ligation and Fyv6 promotes usage of consensus, BP distal 3ʹ SS.

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Eyal Paz, Sahil Jain ... Abdussalam Azem
    Research Article

    TIMM50, an essential TIM23 complex subunit, is suggested to facilitate the import of ~60% of the mitochondrial proteome. In this study, we characterized a TIMM50 disease-causing mutation in human fibroblasts and noted significant decreases in TIM23 core protein levels (TIMM50, TIMM17A/B, and TIMM23). Strikingly, TIMM50 deficiency had no impact on the steady-state levels of most of its putative substrates, suggesting that even low levels of a functional TIM23 complex are sufficient to maintain the majority of TIM23 complex-dependent mitochondrial proteome. As TIMM50 mutations have been linked to severe neurological phenotypes, we aimed to characterize TIMM50 defects in manipulated mammalian neurons. TIMM50 knockdown in mouse neurons had a minor effect on the steady state level of most of the mitochondrial proteome, supporting the results observed in patient fibroblasts. Amongst the few affected TIM23 substrates, a decrease in the steady state level of components of the intricate oxidative phosphorylation and mitochondrial ribosome complexes was evident. This led to declined respiration rates in fibroblasts and neurons, reduced cellular ATP levels, and defective mitochondrial trafficking in neuronal processes, possibly contributing to the developmental defects observed in patients with TIMM50 disease. Finally, increased electrical activity was observed in TIMM50 deficient mice neuronal cells, which correlated with reduced levels of KCNJ10 and KCNA2 plasma membrane potassium channels, likely underlying the patients’ epileptic phenotype.